Introduction
From 100 to 350 patients per 100 000 inhabitants per year are admitted to hospital care following a traumatic brain injury (TBI) all around the world [1] . About 80% of these patients are classified as mild head injury [Glasgow Coma Scale (GCS) [14] [15] , 10% as moderate (GCS 9-13) and 10% as severe head injuries (GCS <9). The development of an intracranial posttraumatic hematoma complicates 25-45% of severe TBI, 3-12% of moderate TBI and 1-3% of mild TBI. As many as 100 000 patients per year may require surgical management of a posttraumatic intracranial hematoma in the United States alone [2 ] . The results of surgical management vary with the type of hematomas: already in 1982 it was reported that patients treated with an admission GCS from 3 to 5 have a mortality of 74% in the case of subdural hematoma, of 50% in the case of intraparenchymal lesions and of 36% in the case of epidural hematomas [3] . In the same years it was shown that with a good neurotrauma organization and with timely evacuation, mortality in epidural hematomas could have been zero in the future [4] . Unfortunately this was not the case and even contemporary reports from Europe show a mortality from 6% (pure epidural hematomas) to 33% (cases with associated lesions) [5] . Furthermore, observational studies show different attitudes toward indications for surgery and decompressive craniectomies in posttraumatic intracranial hematomas both in Europe [6 ] and in the USA [7] .
Background
A review of surgical management of TBI was recently published in a supplement of Neurosurgery [2 ] by an international panel of experts. Differently from the guidelines for management of severe head injuries [8] where three standards and more than 10 guidelines were reported, in this review all reported papers were at the level of simple options. This is only in part due to the 'parachute' effect [9] : no patients with large posttraumatic hematoma will be randomized to a nonsurgical arm in a level I study. Therefore, although ranking surgical evacuation of large posttraumatic hematomas as an 'option' would be consistent with guidelines methodology, it may not be consistent with the best medical practice [10] . A multicenter observational study showed in fact that the current practice is emergency surgical evacuation in 93% of cases of large subdural hematomas [6 ] . There are, however, uncertainties concerning surgical indications in small extracerebral hematomas and concerning any kind of posttraumatic intraparenchymal damage.
General considerations
Following the publication of the Marshall's computed tomography (CT) classification [11] CT criteria such as a hematoma volume over 25 cm 3 were considered as the 'prevailing' indication for evacuation of posttraumatic hematomas. In this series, patients with evacuated mass lesions (>25 cm 3 ) had a favorable outcome of 23% as compared to 11% in patients with non-evacuated mass lesions. Unfortunately data from the European Brain Injury Consortium evaluating a series of 724 patients with a moderate-severe TBI did not confirm this finding. The rate of favorable outcomes was 45% in patients with evacuated mass lesions as compared to 42% in non-evacuated mass lesions [12] . This is not surprising: surgical indications are in fact related to many factors including the clinical status, the occurrence of clinical deterioration and CT parameters like the lesion volume but also the amount of midline shift, of cisterns compression and the lesion location [13] .
Specific considerations for extradural hematomas
An acute extradural hematoma of less than 30 cm 3 , with less than 15 mm thickness and with less than 5 mm midline shift in patients with GCS above 8 without neurological deficits can be managed conservatively with serial CT scanners [14] . Whenever a decision of nonsurgical management of acute epidural hematomas is taken, it must be remembered that the enlargement of a small collection is frequent. Sullivan et al. [15] studied 37 (23%) cases of hematoma enlargement in a series of 160 patients with epidural hematomas initially managed conservatively. Mean time to hematoma enlargement was 8 h after injury and 5.3 h after first CT, with no hematoma enlargement later than 36 h from injury. The decision in favor of a conservative management must therefore be combined with a programme for CT follow up with at least a second CT obtained within 6 h from injury.
Specific considerations for acute subdural hematomas
Acute posttraumatic collections of blood in the subdural space have been considered for years as a 'must' for surgical evacuation [16] . In a recent multicenter series of 404 patients operated within 24 h from injury, acute subdural hematomas isolated or in combination with brain contusions still constituted 69% of all patients and 72% of patients with hematoma evacuation plus emergency bone decompression [6 ] . Nevertheless patients with small hematomas (<10mm) and with midline shift under 5 mm may be managed conservatively [17] . We have learned that with the increased availability of emergency care on the scene of accidents, patients are studied much earlier with CT being obtained in some within an hour from injury. In these circumstances a very early CT can show a hematoma in evolution. Differently from epidural hematomas, acute subdural can enlarge but also 'disappear' [18] . In comatose patients with small subdural hematomas an intracranial pressure (ICP) monitoring can guide a careful conservative management [19] .
Specific considerations for traumatic parenchymal lesions
Data from the series already cited published from the European Brain Injury Consortium [6 ] show how intraparenchymal posttraumatic hematomas constitute (in contrast to subdural hematomas) the lesion most frequently (73%) evacuated at some distance from injury. In the absence of well accepted guidelines [13] , the surgical decisions are based on the appearance of clinical deterioration, of CT evolution or rise in ICP. In contemporary practice such events are usually awaited before a decision is made [6 ] . The occurrence of a clinical [20] and radiological [12] worsening has a negative impact on outcome and it could be of utmost importance to identify patients at risk in an earlier stage. Three recent papers [21 ,22,23 ] addressed the question of enlargement of brain contusions. Most of the patients (>70%) showing radiological deterioration are admitted in a clinical condition of mild-moderate head injury [21 ,23 ] . The presence of traumatic subarachnoid hemorrhage on an admission CT is a powerful predictor of contusional evolution as well as the contusional volume on admission [21 ,23 ] with the highest risk in lesions between 5 and 25 cm 3 [21 ] . Older age, sex (men) and coagulation disorders seem also to be related to lesion evolution [22] .
Conclusions on surgery of posttraumatic hematomas
In spite of the absence of class I paper, guidelines have been published [2 ] about surgical management of TBI. A conservative management of selected cases is possible but only when patients with uncertain surgical indications are admitted to neurosurgical centers. The hematomas may evolve over time and the indication for surgery is a dynamic process that can also change over time. This implies, at least in Europe, a new discussion about patients' centralization. A recent British paper [24 ] demonstrated worse outcomes in TBI patients admitted to non-neurosurgical centers in UK and similar data were shown for Italy [25] . The first duty of a neurosurgeon is to evaluate and select patients for admission to specialized centers, even with modern telemedicine systems [25] . This 'selection' must contain all possible surgical candidates. The lesson learned recently is that neither a good clinical status on admission nor a small hematoma on the first obtained CT scan can exclude subsequent surgical indications.
Decompressive craniectomy for treating high intracranial pressure ICP is the most frequent cause of death and disability after severe TBI. When high ICP is not related to evacuable mass lesions, such as in patients with massive unilateral or bilateral brain swelling (diffuse brain injury type III and IV of the Marshall classification), medical treatment is frequently ineffective in controlling ICP. The treatment of increased ICP is generally based on the algorithm proposed by the Brain Trauma Foundation Guidelines (BTFG). In summary, a set of general maneuvers are used (head elevation, normothermia, volume resuscitation, sedation) [26] . If these general maneuvers fail, first line therapeutic measures are started. These measures include cerebrospinal fluid drainage, moderate hypocapnia (P CO2 30-35 mmHg) and osmotic therapies. When these first line measures fail to control ICP, only a few therapeutic options are available unless potentially evacuable mass lesions are found in the CT scan. In this situation, second tier measures should be considered. These include high dose barbiturates, intense hyperventilation (P CO2 <30 mmHg), hypertensive management, mild or moderate hypothermia and decompressive craniectomy. Of these only barbiturates have reached the level of guideline [26] while the remaining second level therapies are considered options, defined by the BTFG as 'strategies for patient management for which there is unclear clinical certainty' about their use [27] .
Background
Despite the recommendations of the BTFG on barbiturates, a systematic review conducted by the Cochrane collaboration did not find any evidence that barbiturates improve outcome in severe TBI [28 ] . Although barbiturates may reduce ICP, this reduction was not associated with lower mortality or improved outcome in survivors [28 ] . Because of this lack of effective second-level measures, alternatives such as moderate hypothermia or decompressive craniectomy should be reconsidered in the treatment of refractory high ICP.
Decompressive craniectomy in the management of traumatic brain injury
Decompressive craniectomy consists of increasing cranial volume by removing a variable amount of bone and opening the duramater, leaving the duramater open or augmented by a duraplasty. The rationale for decompressive craniotomy is that by removing a variable amount of bone we are able to convert the skull from 'a closed box with a finite volume into an open one' [29] . Although almost all pioneers of neurosurgery had performed this surgical procedure, it was Cushing in 1905 who made the first detailed report of subtemporal and suboccipital decompression to alleviate high ICP in patients with brain herniation secondary to inoperable brain tumors [30] . In TBI, decompressive craniectomy can be classified in two different procedures: primary decompressive craniectomy or prophylactic decompression. This term refers to any surgical decompression performed with or without brain tissue removal in patients undergoing surgery for the evacuation of an intracranial lesion [31 ] . The aim of this type of craniectomy is not to control refractory ICP but to avoid expected increases in ICP. The decision is taken by the surgeon based on CT scan or surgical findings (brain swelling, 'tight' brain or difficulties in repositioning the bone flap); secondary decompressive craniectomy refers to any decompressive surgery performed to control ICP refractory to maximal medical therapy.
Effects of secondary decompressive craniectomy on intracranial pressure and outcome
A recent Cochrane systematic review evaluated the effects of secondary decompressive craniectomy on outcome in patients with severe TBI in whom conventional medical therapeutic measures failed to control ICP [31 ] . Randomized or quasi-randomized controlled trials were included in this review. Because of the characteristics of decompressive craniectomy, clinicians cannot be blinded to the type of treatment the patient is allocated to. Consequently, blinding was not used as a criteria for the quality of the trial, but blinding of the evaluator was essential for a study to be considered high quality. This review identified a single randomized controlled trial examining the effect of secondary decompressive craniectomy on death and disability following severe head injury with ICP refractory to maximal medical treatment. This small study was conducted by Taylor et al.
[32] in a pediatric cohort of 27 patients enrolled over a period of 7 years. The authors decided to stop the trial prematurely because the results of an interim analysis showed clear efficacy of the treatment. Mean ICP before allocation was 25.6 AE 8.1 mmHg in the control group and 26.4 AE 7.9 mmHg in the decompressive craniectomy group. Patients allocated to the treatment group underwent a bitemporal craniectomy in addition to maximal medical treatment. The duramater, however, was left intact or scarified in a few cases. Despite this limited surgical decompression, the risk of death in patients treated with decompressive craniectomy was lower than that of patients treated with maximal medical treatment [RR 0.54 (95% CI 0.17-1.72)] and the risk of unfavorable outcome (death, vegetative status or severe disability) in patients treated with decompressive craniectomy was also lower than in the control. This review did not find any evidence to support decompressive craniectomy in reducing the risk of death or disability following TBI in adults.
In the absence of evidence, is decompressive craniectomy justified in adults?
Although no controlled clinical trial has proven that decompressive craniectomy is more effective in improving outcome than maximal medical therapy in adults, many small series and case reports indicate a beneficial effect of secondary decompressive craniectomy on outcome [33 ] . There are two ongoing randomized clinical trials, the RESCUEicp (http://www.rescueicp.com) in Europe and the DECRA study in Australia (http:// www.ntri.com.au/research/clinical/projects.asp), that aim to address this question [34] .
While awaiting stronger evidence, what are our recommendations? In our opinion, the favorable outcome described in many case reports, retrospective series, prospective nonrandomized trials and controlled trials with historical controls suggests that functional outcome might be expected in patients who underwent timely decompressive craniectomy. Consequently, secondary decompressive craniectomy should be considered in patients with diffuse brain injury and high ICP refractory to first or second line therapeutic measures [35 ] .
Surgical technique
Wide variability exists in the surgical procedures used for performing decompressive craniectomy. These variations include removing small to massive amounts of bone, performing unilateral or bilateral bone decompression, opening the duramater, leaving it closed or scarified and sectioning of the falx, among others. The decision to perform unilateral, bilateral or bifrontal decompression should be based on the CT scan findings. In unilateral diffuse brain swelling we recommend performing a large fronto-temporo-parietal unilateral decompressive craniectomy, as recommended in patients with malignant middle cerebral artery infarction. In bilateral diffuse brain swelling, we prefer to perform a bifrontal craniectomy with a large bilateral bone flap extending beyond the coronal suture. Bone removal has to include the most basal part of the temporal bone down to the base of the cranium. We recommend a wide dural opening with anterior division of the falx cerebri to allow the frontal lobes to expand and the temporal lobes to move above the sphenoidal ridge. Some authors advocate the use of vascular tunnels to protect veins at the bony edge [36] .
Small craniectomies are suboptimal in managing these patients. Skoglund et al. [37 ] showed that there is a robust relationship between the size of the craniectomy and the decrease in ICP. Larger craniectomies resulted in greater decreases in ICP. In any decompressive craniectomy the duramater must be opened and a duraplasty used. The importance of this cannot be underestimated. As stated by Cushing, 'The mere removal of bone alone does not usually answer as a palliative measure, for, owing to the inelasticity of the dura, sufficient decompression will not ensue until this membrane has been freely incised or removed' [30] . Several experimental and clinical studies of craniospinal dynamics have confirmed this point. Although some case reports have described good ICP control with duramater scarifications or even with bone decompression alone, it is generally accepted that a large craniotomy, with dura opening and large duraplasty, is the best way to achieve this goal. Yoo et al. [38] evaluated the efficacy of bone decompression alone in a cohort of 22 patients who underwent bilateral decompressive craniotomy to treat high ICP after either TBI or stroke. In this study the authors monitored ICP before surgery, after bone decompression and after opening the duramater. They clearly showed that the maximum ICP reduction was achieved only after opening the duramater [38] . This pivotal study quantified ICP reduction and therefore provides evidence to support opening the duramater in patients undergoing decompressive surgery. Large bone decompression without opening the duramater has to be considered suboptimal. Although this type of procedure might work in children, we do not recommend it. Duraplasty may be carried out with autologous fascia, heterologous tissue or any other material. Despite that we do not have evidence to prove the superiority of any of these materials in particular, we prefer to use lyophilized heterologous grafts.
The removed bone flap should be stored frozen at À808C in sterile conditions. This is a much better option than storing it in the subcutaneous abdominal fat. In our opinion the bone flap should be replaced as early as possible after decompression to avoid the trephine syndrome and to permit early rehabilitation in order to maximize the possibilities of a favorable outcome.
Complications of decompressive craniectomy
Doubts about the benefits of decompressive craniectomy are influenced by its potential adverse effects, such as increased brain edema, subdural collections, cerebrospinal fluid leakage, hydrocephalus or brain infarctions that might occur early after surgery and the much more frequent complications observed at the time of bone flap replacement. In a recent study, Skoglund et al. [37 ] reported that half the patients who underwent decompressive craniectomy had some complications, most of them after bone replacement. It is important to remember that repositioning of the bone flap in these fragile patients has a number of complications that have been underreported, such as epidural collections, local infections, hydrocephalus, cerebrospinal fluid leakage or bone flap resorption. Among them, the most important is infection of the bone flap, requiring its removal and repeated cranioplasty [39] .
Conclusion
Given the dismal outcome of patients with high ICP, it would seem reasonable to include decompressive craniectomy as a last resort in any protocol-driven management when conventional therapeutic measures have failed to control high ICP, operable masses have been ruled out and the patient still has the possibility of a functional outcome. Our recommendations are to exclude from this treatment patients with a devastating neurological injury and predictable poor outcome, such as patients with radiological signs of brainstem damage or very severe diffuse axonal injury.
References and recommended reading
Papers of particular interest, published within the annual period of review, have been highlighted as:
of special interest of outstanding interest Additional references related to this topic can also be found in the Current World Literature section in this issue (p. 226). 
